Clinical trials: Pathological Complete Response
Fasting Mimicking Diet, Breast Cancer
DIetary REstriction as an Adjunct to Neoadjuvant ChemoTherapy for HER2 Negative Breast Cancer
Preclinical studies provide strong support for the concept that fasting evokes resistance to multiple forms of stress. Fasting reduces plasma levels of growth factors and modulates intracellular nutrient sensing systems, thereby…
- Conditions
- Fasting Mimicking Diet, Breast Cancer, Neoadjuvant Chemotherapy, Pathological Complete Response
- Trial name
- DIRECT (NCT02126449)
- Testing
- Fasting mimicking diet
- Where
- 15 sites in Netherlands
- Volunteers
- 131 people
- Sponsor
- Leiden University Medical Center
Breast Cancer, Pathological Complete Response
Pathological Complete Response Rate in Locally Advanced Breast Cancer With FEC, EC-T, or TC as Neoadjuvant Chemotherapy
Neoadjuvant chemotherapy (NAC) has become the standard therapy for both locally advanced and early-stage breast cancer in recent years for the improvement breast conserving surgery rate and the evaluation of treatment response in…
- Conditions
- Breast Cancer, Pathological Complete Response, Neoadjuvant Chemotherapy
- Trial name
- NCT03349177
- Testing
- Epirubicin, Fluorouracil, Docetaxel
- Volunteers
- 200 people
- Sponsor
- Zhiyong Yu